A multicenter investigator-initiated Phase 2 trial of E7090 in patients with advanced or recurrent solid tumor with fibroblast growth factor receptor ( FGFR ) gene alteration: FORTUNE trial
BMC Cancer(2022)
关键词
Fibroblast growth factor receptor, Gene fusion, Mutation, Amplification, Precision medicine
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要